The biotech market is not well understood here in AU.
NEU needs to dual list on the Nasdaq. Just look at Prana (PBT) to see the impact that a listing on the Nasdaq can have. I hold both. Was watching PBT or PRAN the ticker on the Nasdaq seeing it skyrocket, excited about that but also wishing that my other Gem in NEU was also on the Nasdaq.
This is purposely being held back, won't let it drop below 10 cents , won let it go beyond 11 cents. Some major high net worth investor is drip feeding & accumulating NEU.
Excited for the future,
Pandelis
should dual list on nasdaq a la pbt
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.17 |
Change
0.070(0.35%) |
Mkt cap ! $2.578B | |||
| Open | High | Low | Value | Volume |
| $20.39 | $20.53 | $20.14 | $4.102M | 202.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 249 | $20.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.31 | 790 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |